188Re-BMEDA-liposome
N/A
Report date: 2025/10/20 14:38:47
NME
Base Information
Drug Name188Re-BMEDA-liposome
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Atomic Research Institute, Taiwan
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Atomic Research Institute, Taiwan
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A